The neuromuscular specialists participate in clinical trials and basic research. Dr. Melanson is currently investigating the role of a novel sodium channel antagonist for neuropathic pain.
Clinical trial: use of a novel sodium channel antagonist for neuropathic pain
Basic science: investigation into the nuclear membrane protein structure and protein interactions in Bethlem’s muscular dystrophy
Sponsor: self sponsored
Local Principal Investigator: Dr Michel Melanson